Reimbursement & Directory Validation Update

Reimbursement Change
Effective Oct. 1, BCBSWY will begin using J-code level pricing for J-1745 (infliximab). We will no longer be pricing this medication at the NDC code level. Reimbursement will be at the biosimilar rate.

Directory Validation Tip
In Availity, beneath the user account, please select “Manage My Organization” to make updates. (See screenshot below.) Additional instructions are located here to help you find NPI and tax ID combinations. This helps facilitate compliance with the No Surprises Act (NSA) provider directory validation requirements. The NSA requires you confirm this information with us every 90 days, so your information can continue to be listed in our public directory.

Share

Related Posts
Cervical Cancer Screening Codes & Provider Directory Tool
Cervical Cancer Screening Codes As the year kicks into gear, it is important to remember the benefit of women receiving cervical cancer screenings early,…
Availity Webinar, Advanced Claim Editing & Coding Advice
Availity Webinar Reminder As a reminder, BCBSWY is offering training via Availity Essentials for multi-payer appeals. The tool saves Providers time by allowing you…
Telemedicine Services Guidance & Directory Validation Updates
Telemedicine Services Guidance Updated BCBSWY recently updated our list of services that can be covered under telemedicine. To learn more view the Telemedicine update…

Fewer Hassles. Better Service.

Back to Top